EU throws shade as UK approves COVID-19 vaccine after 10-day review

Enlarge / UK Prime Minister Boris Johnson poses for a photograph with a vial of the AstraZeneca/Oxford University COVID-19 candidate vaccine, known as AZD1222, at Wockhardt’s pharmaceutical manufacturing facility on November 30, 2020 in Wrexham, Wales. (credit: Getty | WPA Pool)

Regulators and health officials in the United Kingdom are waving the Union Jack today, celebrating being the first country to approve the COVID-19 vaccine developed by US-based pharmaceutical giant Pfizer and German biotech firm BioNTech.

The frontrunner vaccine is under review in regulatory agencies around the world, including the US Food and Drug Administration and the European Union’s European Medicines Agency. But the UK was the first to give the vaccine the green-light after a remarkably short 10-day review. In non-pandemic times, such reviews typically take months.

“The UK was the first country to sign a deal with Pfizer/BioNTech—now we will be the first to deploy their vaccine,” UK Business Secretary Alok Sharma wrote in a tweet. “In years to come, we will remember this moment as the day the UK led humanity’s charge against this disease.”

Read 11 remaining paragraphs | Comments

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

six + 13 =

This site uses Akismet to reduce spam. Learn how your comment data is processed.